Fluorometholone-induced cataract after photorefractive keratectomy.

Abstract

The use of topical corticosteroids following photorefractive keratectomy (PRK) is widespread. The major complications of potent corticosteroids are glaucoma and cataract formation; in order to decrease these complications, 0.1% fluorometholone administration is usually preferred after PRK. We report here a case of lens opacification which was induced by 0.1% fluorometholone administration after PRK in a period of 4 months. To our knowledge, this is the first reported case of 0.1% fluorometholone-induced cataract after PRK.

• Authors: K Bilgihan, G Gürelik, F Akata, B Hasanreisoglu
• Journal: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde (Ophthalmologica) Vol. 211 Issue 6 Pg. 394-6 ( 1997) ISSN: 0030-3755 [Print] Switzerland
• PMID: 9380362 (Publication Type: Case Reports, Journal Article)

Chemical References

• Anti-Inflammatory Agents
• Glucocorticoids
• Ophthalmic Solutions
• Fluorometholone

Topics

• Administration, Topical
• Adult
• Anti-Inflammatory Agents (administration & dosage, adverse effects)
• Astigmatism (surgery)
• Cataract (chemically induced, pathology)
• Cornea (surgery)
• Female
• Fluorometholone (administration & dosage, adverse effects)
• Follow-Up Studies
• Glucocorticoids
• Humans
• Lasers, Excimer
• Lens, Crystalline (drug effects, pathology)
• Ophthalmic Solutions
• Photorefractive Keratectomy